CEPVVSKRSA• 12 Months (Normalized)
CEPV vs KRSA (Cantor Equity Partners V Inc. vs Korsana Biosciences Inc.)
Showing Closing Date Range from Sep, 11, 2025 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CEPV Performance $10.39
+0.87%
Cantor Equity Partners V Inc.
Normalized Baseline0.00%
KRSA Performance $31.91
+78.74%
Korsana Biosciences Inc.
Normalized Baseline0.00%
Alpha Spread Margin KRSA LEADS
-77.87%
KRSA outperforming by 77.87%
CEPVKRSA
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CEPV KRSA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | CEPV Price | CEPV Gain (%) | KRSA Price | KRSA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $10.39 | +0.87% | $31.91 | +78.74% | -77.87% |
| Sep 10, 2026 | $10.39 | +0.87% | $24.56 | +37.59% | -36.72% |
| Sep 09, 2026 | $10.39 | +0.87% | $26.20 | +46.78% | -45.91% |
| Sep 08, 2026 | $10.39 | +0.87% | $23.52 | +31.76% | -30.89% |
| Sep 04, 2026 | $10.38 | +0.78% | $29.75 | +66.67% | -65.89% |
| Sep 03, 2026 | $10.38 | +0.78% | $34.72 | +94.51% | -93.73% |
| Sep 02, 2026 | $10.38 | +0.78% | $31.64 | +77.25% | -76.47% |
| Sep 01, 2026 | $10.38 | +0.78% | $29.19 | +63.53% | -62.75% |
| Aug 31, 2026 | $10.38 | +0.78% | $25.76 | +44.31% | -43.53% |
| Aug 28, 2026 | $10.38 | +0.78% | $26.53 | +48.63% | -47.85% |
| Aug 27, 2026 | $10.38 | +0.78% | $27.93 | +56.47% | -55.69% |
| Aug 26, 2026 | $10.39 | +0.87% | $29.05 | +62.75% | -61.88% |
| Aug 25, 2026 | $10.39 | +0.87% | $28.00 | +56.86% | -55.99% |
| Aug 24, 2026 | $10.39 | +0.87% | $27.51 | +54.12% | -53.25% |
| Aug 21, 2026 | $10.39 | +0.87% | $27.23 | +52.55% | -51.68% |
Page 1 of 17